Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP172052.RAVzPwYrgb6XmBktWEk9qJVFkrZ6AEjFKvZ-R8GrHVIFM130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172052.RAVzPwYrgb6XmBktWEk9qJVFkrZ6AEjFKvZ-R8GrHVIFM130_provenance.
• NP186613.RARIh_cm5_Uf0GJdC9JD4zsVoIFh14Nf-E7Kea8aUIkjA130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186613.RARIh_cm5_Uf0GJdC9JD4zsVoIFh14Nf-E7Kea8aUIkjA130_provenance.
• NP663149.RApQgYQCnQSqWBr2-0MJXJ_Ou-cDInVmU5dJhl_J1eJQg130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663149.RApQgYQCnQSqWBr2-0MJXJ_Ou-cDInVmU5dJhl_J1eJQg130_provenance.
• NP807998.RAh_ZWEO0aszMu-iX0Etp1w10GS1AS23EK2k4Yf7TIC9M130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807998.RAh_ZWEO0aszMu-iX0Etp1w10GS1AS23EK2k4Yf7TIC9M130_provenance.
• NP864005.RAVDK_YYsiyHKxgSgInWTwb10zpJky5hK3s-BVYd2Mp20130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864005.RAVDK_YYsiyHKxgSgInWTwb10zpJky5hK3s-BVYd2Mp20130_provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP406843.RAffZlqSXoi0B6IIDF2wV8sFskyFldcXluqr67niFhENw130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406843.RAffZlqSXoi0B6IIDF2wV8sFskyFldcXluqr67niFhENw130_provenance.
• NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619010.RARHYc7-PO5_npd_oHiEiCCncEP2HfEkJaVa2lKZYtatY130_provenance.
• NP413013.RAgDy1oeB7z4ccRvJYoOrBjEpVhyzeJY_dKjCZWJDZQ3U130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413013.RAgDy1oeB7z4ccRvJYoOrBjEpVhyzeJY_dKjCZWJDZQ3U130_provenance.
• NP811818.RAJUPHego-Dfe7M_1p9bcbAC3U_jqThLRU9a3-yQPmTV8130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811818.RAJUPHego-Dfe7M_1p9bcbAC3U_jqThLRU9a3-yQPmTV8130_provenance.
• NP619009.RAwfT7mdv5dC4KjrONaW9cXiuykAfay5uPIVzGY4KSNnY130_assertion description "[In 44 patients with coronary artery disease or hypercholesterolemia (not on lipid-lowering treatment), lipid profile and endothelial function (brachial artery flow-mediated dilation, FMD) were measured at baseline and after treatment with statins for 8-12 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619009.RAwfT7mdv5dC4KjrONaW9cXiuykAfay5uPIVzGY4KSNnY130_provenance.